克里斯汀·伊莱恩·琼斯

作为监管事务副总裁, I lead a global team responsible for the regulatory activities relating to our respiratory and immunology treatments. 我的团队与R的同事一起工作&D – from early discovery science through to late-stage development, including supporting clinical trials – to ensure that our medicines have the highest quality evidence required to gain approval by international regulatory bodies. 

It is our responsibility to apply innovative regulatory strategies to our respiratory & immunology pipeline, so that life-changing medicines can reach patients as quickly as possible. 

我于2020年加入澳门葡京网赌游戏, and since then I have been very impressed by our exciting pipeline: from vaccine development to our longstanding leadership in asthma and COPD research, and more recently our ambition to apply our strengths in respiratory research to the treatment of a wide range of immunology diseases. 

Before this role, I spent 10 years at GSK as Medicine Development Leader for respiratory medicines. I initially trained as a pharmacist and did a Ph.D. in Pharmaceutical Sciences  before beginning my career at GSK. Before my Medicine Development Leader role, I took on numerous and diverse Regulatory Affairs roles. I love roles where you can work with everyone across R&D – scientists discovering the molecules and development scientists producing the medicine, but also commercial colleagues who enable patients to gain access to our life changing medicines.